- **Stevanato Group** has significantly expanded its drug delivery system manufacturing capacity with a **multi-million investment** at its facility in Bad Oeynhausen, northern Germany.  **[1106644_dcb53aec45e542d68d259df3e3d13fdb_0]** 
- The expansion includes over **2,500 square meters** of advanced production space and an **ISO 8 cleanroom environment** for injection molding and automated assembly operations.  **[1106644_dcb53aec45e542d68d259df3e3d13fdb_0]** 
- This initiative aims to strengthen global supply-chain integration, support proprietary devices such as the **Aidaptus® autoinjector** and **Alina® pen injector platforms**, and enhance operational flexibility and speed-to-market.  **[1106644_dcb53aec45e542d68d259df3e3d13fdb_0]** 
- The expansion addresses the **accelerating demand** for drug delivery devices and rising patient adoption for more convenient, personalized treatment options.  **[1106644_dcb53aec45e542d68d259df3e3d13fdb_0]**

CHINA PHARMA HOLDINGS (CPHI)